BoneSupport

IPO

Bone Void Filling — Preventing Reinfection, Promoting Regeneration

Public · Lund, Sweden · Founded 1999

Headquarters
Lund
Employees
201–500
Founded
1999
Business Model
B2B
Type
Public

About

BoneSupport (BONEX: Stockholm) is a Swedish orthobiologics company specializing in injectable calcium sulfate/hydroxyapatite bone substitute products under the CERAMENT brand. The company's products are designed to fill bone voids caused by trauma, tumors, and joint revisions while simultaneously delivering antibiotics (CERAMENT G and CERAMENT V) to prevent reinfection and promote natural bone regeneration. Founded in 1999 by Professor Lars Lidgren at Ideon Science Park in Lund, Sweden, BoneSupport is commercially active in the U.S. and Europe and is listed on Nasdaq Stockholm.

Summary

BoneSupport is a Biotech company based in Lund, Sweden, founded in 1999.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

IPOJun 2017

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BoneSupport on Indexed.vc
<a href="https://indexed.vc/companies/bonesupport"><img src="https://indexed.vc/api/badge/company/bonesupport" alt="BoneSupport on Indexed.vc" width="260" height="76" /></a>